Cosciens Biopharma Inc. Files 6-K Report
Ticker: CSCIF · Form: 6-K · Filed: Apr 14, 2025 · CIK: 1113423
| Field | Detail |
|---|---|
| Company | Cosciens Biopharma INC. (CSCIF) |
| Form Type | 6-K |
| Filed Date | Apr 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, corporate-update, foreign-private-issuer
TL;DR
Cosciens Biopharma (formerly Aeterna Zentaris) filed a 6-K on 4/14/25, confirming its foreign private issuer status and corporate details.
AI Summary
Cosciens Biopharma Inc. filed a Form 6-K on April 14, 2025, reporting as a foreign private issuer. The company, formerly known as Aeterna Zentaris Inc. and Aeterna Laboratories Inc., is incorporated in A6 and has a fiscal year end of December 31. Its principal executive offices are located in Toronto, Ontario, Canada.
Why It Matters
This filing provides an update on the company's status and administrative details, which is important for investors tracking its regulatory compliance and corporate structure.
Risk Assessment
Risk Level: low — This filing is primarily administrative and does not contain new financial or operational information that would significantly alter risk.
Key Numbers
- 001-38064 — SEC File Number (Identifies the company's registration with the SEC)
- 0001113423 — Central Index Key (Unique identifier for the company in SEC filings)
Key Players & Entities
- COSCIENS Biopharma Inc. (company) — Filer
- Aeterna Zentaris Inc. (company) — Former Company Name
- AETERNA LABORATORIES INC (company) — Former Company Name
- Norton Rose Fulbright Canada, LLP (company) — Legal Counsel / Address Provider
- 20250414 (date) — Filing Date
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report information as a foreign private issuer, including administrative details and confirmation of its filing status.
When was this Form 6-K filed with the SEC?
The Form 6-K was filed on April 14, 2025.
What were the previous names of COSCIENS Biopharma Inc.?
The company was formerly known as Aeterna Zentaris Inc. and Aeterna Laboratories Inc.
Where are COSCIENS Biopharma Inc.'s principal executive offices located?
Its principal executive offices are located at c/o Norton Rose Fulbright Canada, LLP, 222 Bay Street, Suite 3000, PO Box 53, Toronto ON M5K 1E7.
Does the company file annual reports under Form 20-F or 40-F?
The company indicates it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 14, 2025 regarding COSCIENS Biopharma Inc. (CSCIF).